Article Title,Year,Volume,Issue,Page Range,Author
Topical capsaicin. The fire of a 'hot' medicine is reignited,2010,11,8,1359-1371,Papoiu
Pharmacotherapy of major depressive disorder in adolescents,2010,11,3,375-386,Masi
Fluoxetine--do the benefits outweigh the risks in adolescent major depression?,2005,6,1,147-150,Doggrell
Pharmacotherapy of insomnia,2012,13,9,1243-1260,Ioachimescu
An update on antidepressant use and suicidality in pediatric depression,2012,13,15,2119-2130,Findling
The use of antidepressants in bipolar disorder patients with depression,2015,17,1,17-25,Singh
Pharmacological treatment of children and adolescents with depression,2016,17,17,2273-2279,Vitiello
Current pharmacotherapy options for conduct disorders in adolescents and children,2019,20,5,571-583,Bor
Recommendations for the pharmacological management of irritability and aggression in conduct disorder patients,2019,ePub,ePub,ePub,Masi
Treating epileptic emergencies - pharmacological advances,2016,17,16,2227-2234,Zelano
The pharmacotherapeutic management of premenstrual dysphoric disorder,2023,24,1,145-151,Frey
Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment,2021,22,9,1143-1155,Baldessarini
Bipolar disorders: new approaches to therapy,2001,2,4,601-612,Watson
Pharmacotherapy for bipolar depression: an economic assessment,2004,5,5,1101-1107,Bowden
Prepubertal bipolar disorder: available pharmacological treatment options,2005,6,4,547-560,Masi
Advances in the management of organophosphate poisoning,2007,8,10,1451-1464,Graham
New treatment options for panic disorder: clinical trials from 2000 to 2010,2011,12,9,1419-1428,Nardi
The pharmacological management of treatment-resistant depression: what does the future hold?,2023,24,18,1923-1925,Serretti